1.Glycemic and Metabolic Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes: A Single-Centre Clinical Audit
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):44-
Introduction:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
improve glycemic control, promote weight loss, reduce
insulin requirements, and confer cardiometabolic benefits
in type 2 diabetes mellitus (T2DM). This audit evaluated
glycemic and metabolic outcomes of GLP-1 RAs in T2DM
patients at a single-centre diabetes clinic.
Methodology:
This audit included T2DM patients who initiated GLP1 RAs between January 2022 and March 2025 at Hospital
Sultan Abdul Halim. Primary outcomes were changes in
hemoglobin A1c (HbA1c), body weight, and body mass
index (BMI) at 3 and 12 months. Secondary outcomes
included percentage weight loss, changes in systolic blood
pressure (SBP), insulin total daily dose (TDD), low-density
lipoprotein (LDL) cholesterol, gastrointestinal adverse
effects, and treatment discontinuation.
Results:
Sixteen patients were included; median age was 58.5 years
(interquartile range [IQR] 47.5–65), and 56.3% were female.
Median diabetes duration was 15 years (IQR 11.5–20.3).
Median HbA1c decreased from 9.7% (IQR 8.6–10.4) at
baseline to 8.8% (IQR 7.7–9.1) at 3 months and 7.8% (IQR
7.0–8.5) at 12 months. Body weight decreased from 88.1 kg
(IQR 79.5–122.1) at baseline to 85.0 kg (IQR 75.9–113.7) at
3 months and 82.0 kg (IQR 74.8–117.3) at 12 months. BMI
decreased from 37.8 kg/m² (IQR 31.7–47.1) to 37.3 kg/m²
(IQR 30.7–45.5) at 3 months and 36.0 kg/m² (IQR 30.1–45.6)
at 12 months.
At 12 months, weight loss was 5.8% (IQR 3.0–8.0), with
56.5% achieving >5% weight reduction. In all, 93.8%
achieved >1% HbA1c reduction. Mean SBP decreased by
10 ± 20 mmHg, LDL cholesterol 0.29 mmol/L (IQR -0.77
to 0.07), and insulin TDD 8 units/day (IQR -13 to 10). No
gastrointestinal adverse effects reported. Three patients
(18.8%) discontinued treatment due to excessive weight
loss, treatment plateau, and limited drug availability.
Conclusion
From our single-centre experience, the observed improvements in glycemic and metabolic outcomes support the
benefits of GLP-1 RAs in managing T2DM.
Diabetes Mellitus, Type 2
;
Glucagon-Like Peptide-1 Receptor Agonists
;
Clinical Audit
2.A Clinical Audit of Diabetic Retinopathy Screening Among Type 2 Diabetes Mellitus Patients Attending Pusat Perubatan Angkatan Tentera, Sg Besi
Maizatulilfah Miskan ; Hasliza Abu Hassan ; Ng Kien Keat ; Ambigga Devi ; Aida Jaffar ; Siti Salmiah Awang
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):44-
Introduction:
Diabetic retinopathy (DRP) is the most common microvascular complication of diabetes, affecting approximately
30% of patients with type 2 diabetes and over half of
those with type 1 diabetes. It remains a leading cause of
preventable blindness among adults worldwide. Early
stages are frequently asymptomatic, making regular
diabetic eye screening essential to detect sight-threatening
changes before irreversible vision loss occurs. In Malaysia,
where diabetes prevalence has reached 15.6% among
adults (NHMS 2023), the effective implementation of
annual retinal screening is crucial. Malaysian National
Clinical Practice Guidelines recommend an annual retinal
screening among type 2 diabetes mellitus (T2DM) patients.
This clinical audit evaluated adherence to DRP screening.
Methodology:
A retrospective clinical audit was conducted at Pusat
Perubatan Angkatan Tentera (PPAT), Kem Sungai Besi, to
evaluate compliance with national DR screening standards
among adults with T2DM. Thirty eligible patient records
were reviewed. Three key indicators were assessed: (1)
documentation of visual acuity at diagnosis, (2) annual
fundoscopy, and (3) referral for fundus photography within
the preceding 12 months. Performance was benchmarked
against the 80% standard. Data were analyzed descriptively.
Results:
The median age group was 55–59 years, with equal gender
distribution. Screening adherence was substantially below
target: visual acuity assessment at diagnosis, 23.3%; annual
fundoscopy, 26.7%; and fundus imaging referral, 36.7%.
All screening indicators were below the recommended
standard.
Conclusion
This audit reveals a significant implementation gap between national guidelines and routine practice. Structured
workflow integration and documentation reinforcement
strategies need to be emphasized. Additional measures include strengthening patient education and reinforcing
guideline-based practice through regular CME sessions.
However, a re-audit has not yet been conducted at the time
of clinical audit reporting. An ongoing evaluation will be
essential to determine the effectiveness and sustainability
of these interventions in reducing preventable diabetic
vision loss at PPAT Sungai Besi.
Humans
;
iabetes Mellitus, Type 2
;
Diabetic Retinopathy
;
Clinical Audit
3.Epidemiology of paediatric intensive care unit admissions, deaths and organ donation candidacy: A single-centre audit.
John Zhong Heng LOW ; Joel Kian Boon LIM ; Herng Lee TAN ; Rudimar Martinez FERNANDEZ ; Samsudin Bin NORDIN ; Yee Hui MOK ; Judith Ju-Ming WONG
Annals of the Academy of Medicine, Singapore 2024;54(1):17-26
INTRODUCTION:
There are limited reports on the epidemiology of paediatric intensive care unit (PICU) admissions, deaths and organ donation candidacy. We aimed to describe PICU admission characteristics and outcomes, determine risk factors for mortality, and perform an independent assessment of missed organ donation opportunities.
METHOD:
We adopted a clinical audit design recruiting consecutive patients admitted to a single-centre multidisciplinary PICU from June 2020 to December 2023. Clinical characteristics and outcomes of survivors and non-survivors were described. Multivariable regression was performed to identify independent risk factors for mortality. Organ donation candidacy was evaluated by an independent team based on the criteria by Singapore's National Organ Transplant Unit.
RESULTS:
There were 1766 PICU admissions with mean age ± standard deviation of 5.9 ± 6.0 years. Surgical admissions accounted for 707/1766 (40%), while the most common medical admission category was respiratory (416/1766; 23.6%). The majority of 983/1766 (55.7%) had a chronic comorbidity and 312/1766 (17.6%) were dependent on at least 1 medical technology device. Mortality occurred in 99/1766 (5.6%). After adjusting for elective admissions and admission category; comorbidity with adjusted odds ratio (aOR) 95% confidence interval (CI) 3.03 (1.54-5.96); higher Pediatric Index of Mortality 3 (PIM 3) score with aOR 1.06 (95% CI 1.04-1.08); and functional status scale with aOR 1.07 (95% CI 1.00-1.13) were associated with mortality. Among non-survivors, organ donor candidacy was 21/99 (21.2%) but successful organ donation occurred in only 2/99 (2.0%).
CONCLUSION
In this single-centre audit, comorbidities, PIM 3 score and functional impairment were associated with mortality. Efforts are needed to improve paediatric organ donation rates.
Humans
;
Male
;
Female
;
Tissue and Organ Procurement/statistics & numerical data*
;
Intensive Care Units, Pediatric/statistics & numerical data*
;
Child, Preschool
;
Child
;
Infant
;
Singapore/epidemiology*
;
Risk Factors
;
Patient Admission/statistics & numerical data*
;
Hospital Mortality
;
Adolescent
;
Medical Audit
;
Comorbidity
;
Clinical Audit
4.AUDIT ON VALIDITY AND ADEQUACY OF CONSENT FORMS FOR OPHTHALMOLOGY LASER PROCEDURES AND ANGIOGRAPHY IN A TERTIARY HOSPITAL
Zen Kuang Tham ; Sharifah Azira Mohd Taufik ; Ee Zhen Ong ; Norlina Ramli
Journal of University of Malaya Medical Centre 2023;26(2):139-147
The importance of complete and valid written consent for medical procedure is indisputable. Written consent forms for ophthalmology related laser procedures and angiography were audited against guidelines regarding validity and adequacy. A full cycle clinical audit was carried out at a tertiary hospital providing ophthalmology service. A preintervention audit was performed in 2018 where consent forms of all ophthalmology related laser procedures and angiography were reviewed. Multiple interventions were taken to improve the adherence in obtaining a valid and adequate written consent prior to the post intervention audit. Standards of practice were compared to ‘Guidelines for Consent for Treatment of Patients by Registered Medical Practitioners’ by Malaysian Medical Council (MMC), and ‘Consent Forms in Ophthalmic Practice’ by Dr. Amit Khosla. A total of 412 consent forms were reviewed in the pre-intervention audit of 2018. Adherence to standard was 37.14%. In the post intervention audit, 256 forms were reviewed, and the adherence improved to 85.94%. Interventions taken include briefing to stakeholders, formulating a standardized risks checklist and multiple checks were done to ensure the interventions were adhered to by the doctors. The significant improvement in adequacy and validity of consent taking for ophthalmology related laser procedures and angiography showed that the interventions taken, were indeed useful. However, continuous effort in maintaining the standard is crucial for patient care and safety.
Clinical Audit
5.Design and Application of Ultrasound Audit Workstation System.
Xiao LU ; Yong ZHANG ; Xin LI ; Boyuan DING ; Li QIU ; Yan LUO
Chinese Journal of Medical Instrumentation 2022;46(4):395-398
According to the problems exist in the original ultrasound system, the study elaborates the design and application of the ultrasound audit workstation system, including the workflow, trace information recording, information management, audit data interaction, application effects, et al. This study points out that the system can optimize the ultrasound process, help to improve the quality and efficiency of ultrasound report audit as well as improve the efficiency of patients' ultrasound examination and medical treatment experience.
Humans
;
Medical Audit
6.A Clinical Audit and Impact of Interventions on Antibiotic Prescribing Practices at a Public Dental Primary Care Clinic
Sarah Wan-Lin Lim ; Diana Brennai Awan ; Thaddius Herman Maling
Archives of Orofacial Sciences 2022;17(1):31-45
ABSTRACT
Inappropriate antibiotic prescribing in dentistry has been widely reported but local studies are scarce.
We aimed to evaluate antibiotic prescribing practices among dental officers in a public dental primary
care clinic against current guidelines: specifically assessing the number, appropriateness, accuracy
of prescriptions, type of antibiotics prescribed and repeated prescribing of the same type of antibiotics
within a specific duration. A retrospective audit consisting of two cycles (1st cycle: July to September
2018, 2nd cycle: July to September 2019) was carried out by manually collecting relevant data of
patients (aged 18 and above) who were prescribed antibiotics from carbon copies of prescription
books. Between each cycle, various interventions such as education through a continuous professional
development (CPD) session, presentation of preliminary findings and making guidelines more accessible
to dental officers were implemented. When the 1st and 2nd cycles were compared, the number of
antibiotic prescriptions issued reduced from 194 to 136 (–30.0%) whereas the percentage of appropriate
prescriptions increased slightly by 4.1%. Inaccurate prescriptions in terms of dosage and duration
decreased (–0.5% and –13.7%, respectively) whilst drug form and frequency of intake increased (+15.7%
and +0.7%, respectively). Repeated prescribing of the same antibiotics by the same officer within a
period of ≤6 weeks no longer occurred. Amoxicillin and metronidazole were most commonly prescribed
in both cycles. Overall, the antibiotic prescribing practices did not closely adhere to current guidelines.
However, clinical audit in conjunction with targeted interventions resulted in improvement in the
antibiotic prescribing patterns. Thus, further intervention and re-audit is necessary.
Anti-Bacterial Agents--administration &
;
dosage
;
Dental Clinics
;
Clinical Audit
7.Clinical audit of current Helicobacter pylori treatment outcomes in Singapore.
Tiing Leong ANG ; Kim Wei LIM ; Daphne ANG ; Yu Jun WONG ; Malcolm TAN ; Andrew Siang YIH WONG
Singapore medical journal 2022;63(9):503-508
INTRODUCTION:
H. pylori eradication reduces the risk of gastric malignancies and peptic ulcer disease. First-line therapies include 14-day PAC (proton pump inhibitor [PPI], amoxicillin, clarithromycin) and PBMT (PPI, bismuth, metronidazole, tetracycline). Second-line therapies include 14-day PBMT and PAL (PPI, amoxicillin, levofloxacin). This clinical audit examined current treatment outcomes in Singapore.
METHODS:
Clinical data of H. pylori-positive patientswho underwent empirical first- and second-line eradication therapies from 1 January 2017 to 31 December 2018 were reviewed. Treatment success was determined by 13C urea breath test performed at least 4 weeks after treatment and 2 weeks off PPI.
RESULTS:
A total of 963 patients (862 PAC, 36 PMC [PPI, metronidazole, clarithromycin], 18 PBMT, 13 PBAC [PAC with bismuth], 34 others) and 98 patients (62 PMBT, 15 PAL, 21 others) received first-and second-line therapies respectively. A 14-day treatment duration was appropriately prescribed for first- and second-line therapies in 65.2% and 82.7% of patients, respectively. First-line treatment success rates were noted for PAC (seven-day: 76.9%, ten-day: 88.3%, 14-day: 92.0%), PMC (seven-day: 0, ten-day: 75.0%, 14-day: 69.8%), PBMT (ten-day: 100%, 14-day: 87.5%) and PBAC (14-day: 100%). 14-day treatment was superior to seven-day treatment (90.8% vs. 71.4%; P = 0.028). PAC was superior to PMC (P < 0.001) but similar to PBMT (P = 0.518) and PBAC (P = 0.288) in 14-day therapies. 14-day second-line PAL and PBMT had similar efficacy (90.9% vs. 82.4%; P = 0.674).
CONCLUSION
First-line empirical treatment using PAC, PBMT and PBAC for 14 days had similar efficacy. Success rates for second-line PBMT and PAL were similar.
Humans
;
Helicobacter pylori
;
Clarithromycin/therapeutic use*
;
Helicobacter Infections/drug therapy*
;
Metronidazole/therapeutic use*
;
Bismuth/therapeutic use*
;
Singapore
;
Drug Therapy, Combination
;
Amoxicillin/therapeutic use*
;
Proton Pump Inhibitors/therapeutic use*
;
Anti-Bacterial Agents/therapeutic use*
;
Treatment Outcome
;
Clinical Audit
8.Interpretive Performance and Inter-Observer Agreement on Digital Mammography Test Sets
Sung Hun KIM ; Eun Hye LEE ; Jae Kwan JUN ; You Me KIM ; Yun Woo CHANG ; Jin Hwa LEE ; Hye Won KIM ; Eun Jung CHOI ;
Korean Journal of Radiology 2019;20(2):218-224
OBJECTIVE: To evaluate the interpretive performance and inter-observer agreement on digital mammographs among radiologists and to investigate whether radiologist characteristics affect performance and agreement. MATERIALS AND METHODS: The test sets consisted of full-field digital mammograms and contained 12 cancer cases among 1000 total cases. Twelve radiologists independently interpreted all mammograms. Performance indicators included the recall rate, cancer detection rate (CDR), positive predictive value (PPV), sensitivity, specificity, false positive rate (FPR), and area under the receiver operating characteristic curve (AUC). Inter-radiologist agreement was measured. The reporting radiologist characteristics included number of years of experience interpreting mammography, fellowship training in breast imaging, and annual volume of mammography interpretation. RESULTS: The mean and range of interpretive performance were as follows: recall rate, 7.5% (3.3–10.2%); CDR, 10.6 (8.0–12.0 per 1000 examinations); PPV, 15.9% (8.8–33.3%); sensitivity, 88.2% (66.7–100%); specificity, 93.5% (90.6–97.8%); FPR, 6.5% (2.2–9.4%); and AUC, 0.93 (0.82–0.99). Radiologists who annually interpreted more than 3000 screening mammograms tended to exhibit higher CDRs and sensitivities than those who interpreted fewer than 3000 mammograms (p = 0.064). The inter-radiologist agreement showed a percent agreement of 77.2–88.8% and a kappa value of 0.27–0.34. Radiologist characteristics did not affect agreement. CONCLUSION: The interpretative performance of the radiologists fulfilled the mammography screening goal of the American College of Radiology, although there was inter-observer variability. Radiologists who interpreted more than 3000 screening mammograms annually tended to perform better than radiologists who did not.
Area Under Curve
;
Breast
;
Fellowships and Scholarships
;
Mammography
;
Mass Screening
;
Medical Audit
;
Observer Variation
;
ROC Curve
;
Sensitivity and Specificity
9.Thoughts on the Witnessed Audit in Medical Device Single Audit Program.
Jing WEN ; Jiangyi XIAO ; Aijun WANG
Chinese Journal of Medical Instrumentation 2018;42(2):122-124
Medical Device Single Audit Program is one of the key projects in International Medical Device Regulators Forum, which has much experience to be used for reference. This paper briefly describes the procedures and contents of the Witnessed Audit in Medical Device Single Audit Program. Some revelations about the work of Witnessed Audit have been discussed, for reference by the Regulatory Authorities and the Auditing Organizations.
Equipment and Supplies
;
Medical Audit
10.Introduction of Quality Management System Audit in Medical Device Single Audit Program.
Jing WEN ; Jiangyi XIAO ; Aijun WANG
Chinese Journal of Medical Instrumentation 2018;42(1):53-55
The audit of the quality management system in the medical device single audit program covers the requirements of several national regulatory authorities, which has a very important reference value. This paper briefly described the procedures and contents of this audit. Some enlightenment on supervision and inspection are discussed in China, for reference by the regulatory authorities and auditing organizations.
China
;
Equipment and Supplies
;
Medical Audit
;
Quality Control


Result Analysis
Print
Save
E-mail